Cited by 489Fungal and yeast genetics researchAntifungal resistance and susceptibilityLipid metabolism and biosynthesis

The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index; 3 of the 137 sources its claims cite were checked for support.

Regulation of Ergosterol Biosynthesis in Saccharomyces cerevisiae

Open access

Abstract

Ergosterol is an essential component of fungal cell membranes that determines the fluidity, permeability and activity of membrane-associated proteins. Ergosterol biosynthesis is a complex and highly energy-consuming pathway that involves the participation of many enzymes. Deficiencies in sterol biosynthesis cause pleiotropic defects that limit cellular proliferation and adaptation to stress. Thereby, fungal ergosterol levels are tightly controlled by the bioavailability of particular metabolites (e.g., sterols, oxygen and iron) and environmental conditions. The regulation of ergosterol synthesis is achieved by overlapping mechanisms that include transcriptional expression, feedback inhibition of enzymes and changes in their subcellular localization. In the budding yeast Saccharomyces cerevisiae, the sterol regulatory element (SRE)-binding proteins Upc2 and Ecm22, the heme-binding protein Hap1 and the repressor factors Rox1 and Mot3 coordinate ergosterol biosynthesis (ERG) gene expression. Here, we summarize the sterol biosynthesis, transport and detoxification systems of S. cerevisiae, as well as its adaptive response to sterol depletion, low oxygen, hyperosmotic stress and iron deficiency. Because of the large number of ERG genes and the crosstalk between different environmental signals and pathways, many aspects of ergosterol regulation are still unknown. The study of sterol metabolism and its regulation is highly relevant due to its wide applications in antifungal treatments, as well as in food and pharmaceutical industries.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This review summarizes ergosterol biosynthesis, transport, detoxification, and regulation in *Saccharomyces cerevisiae*, emphasizing control by sterols, oxygen, osmotic stress, and iron. It highlights Upc2/Ecm22, Hap1, Rox1, Mot3, and other factors, while noting that many regulatory mechanisms remain unresolved.

Key findings

  • Ergosterol biosynthesis is highly energy-consuming, requiring 24 molecules of ATP and 16 molecules of NADPH per ergosterol, and depends on oxygen and iron at multiple enzymatic steps.
  • Regulation occurs through overlapping mechanisms: feedback degradation of Hmg2 via ERAD and Erg1 via Doa10, subcellular localization of Erg enzymes including the ergosome, and transcriptional control by Upc2/Ecm22, Hap1, Rox1, and Mot3.
  • Under sterol depletion, Upc2’s carboxy-terminal domain senses ergosterol; ligand dissociation promotes nuclear translocation and activation of ERG genes, sterol uptake genes (*AUS1*, *PDR11*), *DAN/TIR*, and *PAU* genes.
  • The late ergosterol pathway is a major antifungal target: azoles inhibit Erg11, allylamines inhibit Erg1, morpholines inhibit Erg2/Erg24, and polyenes bind cell-surface ergosterol; *ERG6* deletion or overexpression causes especially compromised phenotypes.

Methods

  • Narrative review synthesizing published literature on *S. cerevisiae* sterol biosynthesis, transport, detoxification, and regulation; no primary experiments, datasets, or systematic search criteria are described.
  • Discusses adaptive responses to sterol depletion, low oxygen, hyperosmotic stress, and iron deficiency, citing genome-wide expression studies but performing no new analysis.

Limitations

  • The authors state that many aspects of ergosterol regulation remain unknown because of the large number of ERG genes and crosstalk between environmental signals and pathways.
  • The authors note conflicting results for Hap1 effects on ERG gene expression under anaerobic conditions, possibly due to strain or media differences, and propose hypotheses that require further study.
  • Evident from the text: as a narrative review, it lacks systematic methodology, quantitative synthesis, and new experimental validation; conclusions rely on cited studies.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/genes11070795

Cites

124 of 124 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Ergosterol biosynthetic pathway in S. cerevisiae. The different color boxes represent the three modules into which the pathway can be divided: the green box is the mevalonate pathway, which occurs in the vacuole and mitochondria; the blue box consists of farnesyl pyrophosphate (farnesyl-PP) biosynthesis and is carried out in the vacuole; and the orange box contains the late pathway, which ends with ergosterol biosynthesis, and mainly takes place in the ER. In addition, farnesyl-PP is used in the synthesis of ubiquinone, dolichol, heme and prenylated proteins (gray box). Enzymes, intermediates, inhibitors and requirements of oxygen, heme and iron are indicated. Enzymes: Erg10, acetyl-CoA C-acetyltransferase; Erg13, HMG-CoA synthase; Hmg1/2, HMG-CoA reductase; Erg12, mevalonate kinase; Erg8, phosphomevalonate kinase; Mvd1/Erg19, mevalonate pyrophosphate decarboxylase; Idi1, Isopentenyl diphosphate Isomerase; Erg20, farnesyl pyrophosphate synthetase; Erg9, squalene synthase; Erg1, squalene epoxidase; Erg7, lanosterol synthase; Erg11 (Cyp51), lanosterol C-14 demethylase; Erg24, sterol C-14 reductase; Erg25, sterol C-4 methyloxydase; Erg26, sterol C-3 dehydrogenase (C4-decarboxylase); Erg27, sterol C-3 ketoreductase; Erg6, sterol C-24 methyltransferase; Erg2, sterol C-8 isomerase; Erg3, sterol C-5 desaturase; Erg5, sterol C-22 desaturase; Erg4, sterol C-24 reductase. Inhibitors: statins target Hmg1/2; allylamines inhibit Erg1; azoles inhibit Erg11; morpholines target Erg2 and, mainly, Erg24; polyenes bind ergosterol.
Figure 1 Ergosterol biosynthetic pathway in S. cerevisiae. The different color boxes represent the three modules into which the pathway can be divided: the green box is the mevalonate pathway, which occurs in the vacuole and mitochondria; the blue box consists of farnesyl pyrophosphate (farnesyl-PP) biosynthesis and is carried out in the vacuole; and the orange box contains the late pathway, which ends with ergosterol biosynthesis, and mainly takes place in the ER. In addition, farnesyl-PP is used in the synthesis of ubiquinone, dolichol, heme and prenylated proteins (gray box). Enzymes, intermediates, inhibitors and requirements of oxygen, heme and iron are indicated. Enzymes: Erg10, acetyl-CoA C-acetyltransferase; Erg13, HMG-CoA synthase; Hmg1/2, HMG-CoA reductase; Erg12, mevalonate kinase; Erg8, phosphomevalonate kinase; Mvd1/Erg19, mevalonate pyrophosphate decarboxylase; Idi1, Isopentenyl diphosphate Isomerase; Erg20, farnesyl pyrophosphate synthetase; Erg9, squalene synthase; Erg1, squalene epoxidase; Erg7, lanosterol synthase; Erg11 (Cyp51), lanosterol C-14 demethylase; Erg24, sterol C-14 reductase; Erg25, sterol C-4 methyloxydase; Erg26, sterol C-3 dehydrogenase (C4-decarboxylase); Erg27, sterol C-3 ketoreductase; Erg6, sterol C-24 methyltransferase; Erg2, sterol C-8 isomerase; Erg3, sterol C-5 desaturase; Erg5, sterol C-22 desaturase; Erg4, sterol C-24 reductase. Inhibitors: statins target Hmg1/2; allylamines inhibit Erg1; azoles inhibit Erg11; morpholines target Erg2 and, mainly, Erg24; polyenes bind ergosterol.CC BY · PubMed Central
Figure 2 Structure and regulation of the S. cerevisiae Upc2 transcriptional factor. (A) Schematic representation of the primary structure of yeast Upc2 protein. NLS, nuclear localization signal. (B) Proposed model for the transcriptional regulation of Upc2. Under high-sterol conditions, Upc2 associates to ergosterol (Erg) and localizes to the cytosol. Although the mechanism is currently unknown, it has been proposed that Upc2 stays in the cytosol either because it interacts with a cytosolic protein or because its NLS is not available for nuclear import. Upon sterol depletion, ergosterol-free Upc2 undergoes a conformational change that allows its import to the nucleus, where it binds to ERG gene promoters to activate their transcription through the recruitment of a co-activator, probably the SAGA complex.
Figure 2 Structure and regulation of the S. cerevisiae Upc2 transcriptional factor. (A) Schematic representation of the primary structure of yeast Upc2 protein. NLS, nuclear localization signal. (B) Proposed model for the transcriptional regulation of Upc2. Under high-sterol conditions, Upc2 associates to ergosterol (Erg) and localizes to the cytosol. Although the mechanism is currently unknown, it has been proposed that Upc2 stays in the cytosol either because it interacts with a cytosolic protein or because its NLS is not available for nuclear import. Upon sterol depletion, ergosterol-free Upc2 undergoes a conformational change that allows its import to the nucleus, where it binds to ERG gene promoters to activate their transcription through the recruitment of a co-activator, probably the SAGA complex.CC BY · PubMed Central
Figure 3 Transcriptional regulation of S. cerevisiae genes involved in ergosterol biosynthesis and uptake in response to low sterols or oxygen. (A) Under normal growth conditions, basal ERG gene expression is mostly maintained by Ecm22 and Hap1. Moreover, Mot3 and Rox1 (in a Tup1-Ssn6-dependent manner) inhibit the expression of hypoxic and ergosterol uptake genes. (B) Upon sterol depletion, Upc2 activates the transcription of ERG genes probably by recruiting the SAGA complex. (C) A drop in oxygen availability decreases heme levels, which lead to the Tup1-Ssn6 and Set4 recruitment by Hap1 to repress the expression of some ERG genes, ROX1 and MOT3. The decrease in Rox1 and Mot3 levels increases the expression of ERG, hypoxic and sterol uptake genes in a Upc2-Ecm22-dependent manner. Finally, Sut1 activates the transcription of AUS1 and DAN1, but not PDR11.
Figure 3 Transcriptional regulation of S. cerevisiae genes involved in ergosterol biosynthesis and uptake in response to low sterols or oxygen. (A) Under normal growth conditions, basal ERG gene expression is mostly maintained by Ecm22 and Hap1. Moreover, Mot3 and Rox1 (in a Tup1-Ssn6-dependent manner) inhibit the expression of hypoxic and ergosterol uptake genes. (B) Upon sterol depletion, Upc2 activates the transcription of ERG genes probably by recruiting the SAGA complex. (C) A drop in oxygen availability decreases heme levels, which lead to the Tup1-Ssn6 and Set4 recruitment by Hap1 to repress the expression of some ERG genes, ROX1 and MOT3. The decrease in Rox1 and Mot3 levels increases the expression of ERG, hypoxic and sterol uptake genes in a Upc2-Ecm22-dependent manner. Finally, Sut1 activates the transcription of AUS1 and DAN1, but not PDR11.CC BY · PubMed Central

Verification

Claims the paper makes

75 Not checked yet · 19 Own interpretation · 1 Supported · 1 Partly supported · accuracy not yet measured

Verify all 134 references — free account

Show all 51 claims

  • It may state two separate claims as one. 39
  • Probably not a substantial claim. 7
45 of 45
  • The paper relies on this without support.

    Changes in ergosterol biosynthesis lead to pleiotropic defects that limit cellular proliferation and adaptation to stresses.

    “However, changes in ergosterol biosynthesis lead to pleiotropic defects that limit cellular proliferation and adaptation to stresses.”
  • The paper relies on this without support.

    The ergosterol biosynthetic pathway constitutes one of the main targets for antifungal agents in health and agriculture.

    “The ergosterol biosynthetic pathway constitutes one of the main targets for antifungal agents in health and agriculture.”
  • The paper relies on this without support.

    Treatment with terbinafine, which targets squalene epoxidase Erg1, results in accumulation of squalene, which can be used for synthesis of terpenes.

    “For instance, the treatment with terbinafine, which targets the squalene epoxidase Erg1, results in the accumulation of squalene, which can be used for the synthesis of terpenes.”
3 of 3

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 124 references

Cited by

Sorted by citations

Items 401–480 of 480

Metadata

Authors
Jordá, T., & Puig, S.
Affiliations
Consejo Superior de Investigaciones Científicas (ES)
Corresponding author
Puig, Sergi
Venue
Genes
Publisher
MDPI AG
Published
2020-07-15
Volume
11
Issue
7
Pages
795
ISSN
2073-4425 (ISSN-L)
OpenAlex
W3043173157
Cited by
489
References
124
Citations by year
2026: 70 · 2025: 103 · 2024: 112 · 2023: 75 · 2022: 74 · 2021: 48 · 2020: 6
FWCI
4.88
Type
journal article
Language
en
Open access
Locations
  • Genes (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Ministerio de Ciencia, Innovación y Universidades (BIO2017-87828-C2-1-P)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
Keywords
ergosterol biosynthesis, Saccharomyces cerevisiae, sterol regulatory element, UPC2, HAP1, roX1, product inhibition, sterol transport, sterol depletion, low oxygen stress, hyperosmotic stress, iron deficiency, fungal cell membrane, antifungal drug targets
MeSH terms
DNA-Binding Proteins, Ergosterol, Promoter Regions, Genetic, Repressor Proteins, Saccharomyces cerevisiae, Sterols, Transcription Factors, Trans-Activators, Gene Expression Regulation, Fungal, Drug Resistance, Fungal, Saccharomyces cerevisiae Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review